Feasibility of a platform trial based on molecular analysis in rare gynecologic cancers


Jubilee Brown, John H. Farley, Thomas J. Herzog, Erin Crane, Al Covens, David Arguello, Pilar Ramos, Wangjuh Chen, Adam ElNaggar.


The aim of this study was to determine whether enough actionable mutations exist in rare gynecologic cancers to justify the design of a platform trial.

Download Publication